" /> Recombinant Anti-WT1 Immunotherapeutic GSK2302024A - CISMeF





Preferred Label : Recombinant Anti-WT1 Immunotherapeutic GSK2302024A;

NCIt synonyms : ASCI GSK2302024A;

NCIt definition : An immunotherapeutic composed of the Wilms tumor 1 (WT1) and an as of yet undisclosed adjuvant, with potential antineoplastic activity. Upon administration, the immune system may be stimulated to exert a cytotoxic T-lymphocyte (CTL) response against WT1-expressing tumor cells. The adjuvant stimulates the immune system's response to WT1. WT1, a tumor-associated antigen (TAA) and transcription factor, is overexpressed in a variety of tumor cell types.;

Molecule name : GSK2302024A;

NCI Metathesaurus CUI : CL433728;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.